Company / Shareholders' Equity
INSMED Inc Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$739.0M
FY2025
5-year range
-$331.9M / $739.0M
FY2021-FY2025
Trend
+158.9%
vs FY2024
Sector context
#61 of 213
Health Care
What the data says
At $739M, INSMED Inc's shareholders' equity ranks #61 of 213 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from -$332M in FY2023 to $739M in FY2025.
Based on SEC 10-K filings.
$739M in FY2025 with a 5-year CAGR of +21.8%.
Improved from -$332M to $739M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +103.3%
- 5-Year CAGR
- +21.8%
- 10-Year CAGR
- -
Sector benchmark
#61 of 213 in Health CareTop 29% of 213This company $739.0M Sector average $2.5B
▼
-71.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 158.9% year-over-year.
- Ranks #61 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $739.0M | +158.9% |
| FY2024 | $285.4M | +186.0% |
| FY2023 | -$331.9M | -477.4% |
| FY2022 | $88.0M | -78.6% |
| FY2021 | $410.5M | +48.8% |
| FY2020 | $275.9M | +5.4% |
| FY2019 | $261.7M | +25.6% |
| FY2018 | $208.3M | -42.3% |
| FY2017 | $361.1M | +133.7% |
| FY2016 | $154.5M | -50.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026